Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

161. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. (PubMed)

News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. In the late 1990s, 3 events pertaining to breast cancer prevention received considerable attention in the US news media: a National Institutes of Health (NIH) consensus panel recommended against routine screening mammography for women in their 40s (January 1997), the National Cancer Institute (NCI) subsequently reversed the recommendation (March 1997), and an NCI-sponsored (...) ), and none left the impression that women should definitely take the drug (24% suggested they probably should). Sixty-five percent of these stories suggested that women faced a genuine choice and would have to weigh the risks and benefits themselves.Most news stories favored routine use of screening mammography and urged caution about using tamoxifen. Almost all noted the potential harms of each preventive strategy; however, the negative aspects of tamoxifen received greater emphasis. Whereas taking

2002 JAMA

162. Will screening mammography in the East do more harm than good?

Will screening mammography in the East do more harm than good? Will screening mammography in the East do more harm than good? Will screening mammography in the East do more harm than good? Leung G M, Lam T H, Thach T Q, Hedley A J Authors' objectives To evaluate the effects of white, population-based mammographic screening when applied to a low-risk Chinese population. Searching MEDLINE (January 1966 to October 2000) and the Cochrane Library were searched for potentially relevant studies (...) ; the search terms were reported. To identify additional trials, bibliographies of systematic reviews and clinical practice guidelines were scanned and experts were consulted. Only studies published in the English language were eligible for inclusion; abstracts were excluded. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion in the review. Specific interventions included in the review Studies of population-based mammography

2002 DARE.

163. The effectiveness of interventions to promote mammography among women with historically lower rates of screening.

The effectiveness of interventions to promote mammography among women with historically lower rates of screening. The effectiveness of interventions to promote mammography among women with historically lower rates of screening The effectiveness of interventions to promote mammography among women with historically lower rates of screening Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer B K Authors' objectives To describe mammography intervention research efforts in diverse (...) populations; to determine which intervention characteristics explain variation in intervention effectiveness; and to assess the effectiveness of particular types of interventions and this benefit for specific populations of women with historically lower use of mammography (older women, women with low incomes and non-Caucasian women). Searching A 'parent' database of articles that described screening mammography interventions (see Other Publications of Related Interest no.2) was established from initial

2002 DARE.

164. Digital mammography versus film-screen mammography: technical, clinical and economic assessments

Digital mammography versus film-screen mammography: technical, clinical and economic assessments Digital mammography versus film-screen mammography: technical, clinical and economic assessments Digital mammography versus film-screen mammography: technical, clinical and economic assessments Ho C, Hailey D, Warburton R, MacGregor J, Pisano E, Joyce J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Ho C, Hailey D, Warburton R, MacGregor J, Pisano E, Joyce J. Digital mammography versus film-screen mammography: technical, clinical and economic assessments. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA) 2002: 55 Authors' objectives The aim of this report is to compare the technical, clinical and potential costs of digital mammography (DM) and film-screen mammography (FSM) within the context of the Canadian health

2002 Health Technology Assessment (HTA) Database.

165. Mammography screening

Mammography screening Mammography screening Mammography screening Morland B, Lund Haheim L, Linnestad K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Morland B, Lund Haheim L, Linnestad K. Mammography screening. Oslo: The Norwegian Knowledge Centre for the Health Services (NOKC) 2002 Authors' objectives This report aims to assess (...) the available evidence on the benefits of mammography screening. Authors' conclusions - Mammography screening in the age group of 50-69 years reduces breast cancer mortality. - The scientific documentation has some weaknesses and the estimated relative risk of reduction in mortality is in the order of 6% to 27%. Other documentation reports a risk reduction of 20-25%. - The effect in the age group 40-49 years is less and uncertain with an even weaker evidence. - Mammography screening does not protect against

2002 Health Technology Assessment (HTA) Database.

166. Full-field digital mammography

Full-field digital mammography Full-field digital mammography Full-field digital mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please use the “contact us” feature (...) on the website. Citation BlueCross BlueShield Association. Full-field digital mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 17(7). 2002 Authors' objectives This Assessment reviews the evidence comparing full-field digital mammography (FFDM) and screen-film mammography (SFM) for use in two settings: the screening population and the population of patients referred for diagnostic mammography based on initial suspicious findings. Radiation exposure, recall rates, biopsy rates

2002 Health Technology Assessment (HTA) Database.

167. Computer-aided detection (CAD) in mammography

Computer-aided detection (CAD) in mammography Computer-aided detection (CAD) in mammography Computer-aided detection (CAD) in mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older (...) reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Computer-aided detection (CAD) in mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 17(17). 2002 Authors' objectives The objective of this Assessment is to evaluate the clinical effectiveness of using computer-aided detection (CAD) as an adjunct to mammography. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms /diagnosis; Computers

2002 Health Technology Assessment (HTA) Database.

168. The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review

The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review Flobbe K, Nelemans P J, Kessels A G, Beets G L, von Meyenfeldt M F, van Engelshoven J M Authors' objectives To assess the diagnostic value of ultrasonography (...) as an adjunct to mammography in detecting breast cancer. Searching MEDLINE, EMBASE, and the Cochrane Library were searched for studies published between 1990 and 2000; the search terms were not reported. Studies in English, German, French, Italian, or Dutch were eligible for inclusion. The reference lists of selected papers were screened for additional studies. Study selection Study designs of evaluations included in the review The authors did not specify any a priori inclusion criteria relating

2002 DARE.

169. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities

Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities Andersen M R, Hager M, Su C, Urban N Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study investigated three different intervention strategies to promote mammography uptake by women in rural areas. The strategies were: individual counselling (IC), which included barrier-specific telephone counselling; community activities (CA), which included video presentations, themed bingo games, poster display, community newsletters and promotional

2002 NHS Economic Evaluation Database.

170. Surveillance mammography after treatment of primary breast cancer: a systematic review

Surveillance mammography after treatment of primary breast cancer: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.

171. Newspaper reporting of screening mammography. (PubMed)

Newspaper reporting of screening mammography. Continuing controversy surrounds screening mammography, particularly for women 40 to 49 years of age. Newspapers are potentially important sources of information on this topic, but it is not known whether they provide well-founded and objective information and recommendations.To examine how screening mammography is reported in newspapers.Cross-sectional descriptive study.6 top-circulation U.S. newspapers, 1990 to 1997.Number of articles about (...) screening mammography, issues covered by the articles, information sources, content and sources of quotes, recommendations cited in articles, and presentation of risks and benefits.The most common theme of newspaper articles about mammography was screening for women 40 to 49 years of age. Thirty-one percent of the articles presented information without citing a source or justification. Quotes and recommendations in the articles were approximately twice as likely to support as to express reservations

2001 Annals of Internal Medicine

172. Cochrane review on screening for breast cancer with mammography. (PubMed)

Cochrane review on screening for breast cancer with mammography. In 2000, we reported that there is no reliable evidence that screening for breast cancer reduces mortality. As we discuss here, a Cochrane review has now confirmed and strengthened our previous findings. The review also shows that breast-cancer mortality is a misleading outcome measure. Finally, we use data supplemental to those in the Cochrane review to show that screening leads to more aggressive treatment.

2001 Lancet

173. Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report)

Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report) Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report) Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report) Luengo S, Munoz A Record Status This is a bibliographic record of a published (...) health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Luengo S, Munoz A. Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report) Madrid: Agencia de Evaluacion de Tecnologias Sanitarias (AETS). Informe de Evaluacion de Tecnologias Sanitarias No. 34. 2001 Authors' objectives The prevention of gynaecologic cancer, especially

2001 Health Technology Assessment (HTA) Database.

174. Inreach and outreach interventions to improve mammography use

Inreach and outreach interventions to improve mammography use Inreach and outreach interventions to improve mammography use Inreach and outreach interventions to improve mammography use Yabroff K R, O'Malley A, Mangan P, Mandelblatt J Authors' objectives To assess the effectiveness of patient-targeted interventions in increasing mammography use when performed outside (outreach) or inside (inreach) the primary care medical setting. Searching MEDLINE was searched for papers published (...) in the English language between 1980 and 2001. The following subject terms were used: 'health behaviour', 'patient compliance', 'patient acceptance of health care', 'attitude of health', 'health education', or 'health promotion', combined with the title terms 'mammogram' or 'mammography'. The reference list of retrieved studies, published reviews, and meta-analyses were also reviewed. The journals Preventative Medicine, American Journal of Preventative Medicine, and Cancer Epidemiology, Biomarkers

2001 DARE.

175. Preventive health care, 2001 update: screening mammography among women aged 40 - 49 years at average risk of breast cancer

Preventive health care, 2001 update: screening mammography among women aged 40 - 49 years at average risk of breast cancer Preventive health care, 2001 update: screening mammography among women aged 40 - 49 years at average risk of breast cancer Preventive health care, 2001 update: screening mammography among women aged 40 - 49 years at average risk of breast cancer Ringash J, Canadian Task Force on Preventive Health Care Authors' objectives To consider the new and updated evidence available (...) , since a review in 1994, about the effect of screening mammography on breast cancer mortality among women aged 40 to 49 years. Searching MEDLINE and Cancerlit were searched from 1966 to June 2000; the search terms were reported. Reference lists were checked for additional studies. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs), or meta-analyses including all eligible RCTs, were eligible for inclusion in the section on the effectiveness

2001 DARE.

176. A population-based cohort study of surveillance mammography after treatment of primary breast cancer

A population-based cohort study of surveillance mammography after treatment of primary breast cancer A population-based cohort study of surveillance mammography after treatment of primary breast cancer A population-based cohort study of surveillance mammography after treatment of primary breast cancer Paszat L, Grunfeld E, van Walraven C, Coyle D, Sawka C, Yun J, McGahan L, Noorani H Z Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Paszat L, Grunfeld E, van Walraven C, Coyle D, Sawka C, Yun J, McGahan L, Noorani H Z. A population-based cohort study of surveillance mammography after treatment of primary breast cancer. Ottawa: Canadian Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologies de la Sante (CCOHTA) 2001: 26 Authors' objectives This report presents

2001 Health Technology Assessment (HTA) Database.

177. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modelled nationwide screening

Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modelled nationwide screening Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modelled nationwide screening Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modelled nationwide screening Wang H, Karesen R, Hervik A, Thoresen S O Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Biannual screening (mammography using two views) for breast cancer was compared to no screening. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study

2001 NHS Economic Evaluation Database.

178. Is screening for breast cancer with mammography justifiable? (PubMed)

Is screening for breast cancer with mammography justifiable? A 1999 study found no decrease in breast-cancer mortality in Sweden, where screening has been recommended since 1985. We therefore reviewed the methodological quality of the mammography trials and an influential Swedish meta-analysis, and did a meta-analysis ourselves.We searched the Cochrane Library for trials and asked the investigators for further details. Meta-analyses were done with Review Manager (version 4.0).Baseline (...) -analysis showed a decrease in breast-cancer mortality but also an increase in total mortality (1.06 [1.04-1.08]); this increase disappeared after adjustment for an imbalance in age.Screening for breast cancer with mammography is unjustified. If the Swedish trials are judged to be unbiased, the data show that for every 1000 women screened biennially throughout 12 years, one breast-cancer death is avoided whereas the total number of deaths is increased by six. If the Swedish trials (apart from the Malmö

2000 Lancet

179. Surveillance mammography after treatment for primary breast cancer

Surveillance mammography after treatment for primary breast cancer Surveillance mammography after treatment for primary breast cancer Surveillance mammography after treatment for primary breast cancer McGahan L, Noorani HZ Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation McGahan L, Noorani HZ. Surveillance mammography after treatment (...) for primary breast cancer. Ottawa: Canadian Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologies de la Sante (CCOHTA) 2000: 17 Authors' objectives This review aims to evaluate the practice of routine surveillance mammography and its impact on disease outcomes. Authors' conclusions Considerable controversy exists regarding the frequency and intensity of surveillance following treatment for breast cancer. This paper is a systematic, structured

2000 Health Technology Assessment (HTA) Database.

180. Mammography screening: mortality rate reduction and screening interval

Mammography screening: mortality rate reduction and screening interval Mammography screening: mortality rate reduction and screening interval Mammography screening: mortality rate reduction and screening interval Harstall C Authors' objectives To determine the scientific evidence for: 1. The effective time interval for mammography screening in asymptomatic women aged 50-69yrs. 2. The effective screening interval in asymptomatic women between the ages of 40-49yrs. 3. The mortality rate reduction (...) of mammography screening in asymptomatic women aged 40-49yrs. Searching MEDLINE, EMBASE, HealthSTAR, Cancerlit, Best Evidence, PubMed, PREMEDLINE, CMA CPG Infobase, U.S. National Guideline Clearinghouse, MD Consult practice guidelines section, DARE, Cochrane Library and the HTA database were searched from 1997 to June 2000 (keywords listed). In addition, the reference lists of retrieved articles were searched along with a National Institutes of Health consensus conference and other published discussion

2000 DARE.